Related Experiment Videos
Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl- current associated with neuroendocrine
L Lemonnier1, R Lazarenko, Y Shuba
1Laboratoire de Physiologie Cellulaire, INSERM EMI 0228, USTL Bât. SN3, 59655 Villeneuve d'Ascq, France.
Endocrine-Related Cancer
|June 11, 2005
Summary
Neuroendocrine differentiation in prostate cancer enhances cell volume regulation. This involves increased chloride currents and better cell survival, offering potential therapeutic insights.
Area of Science:
- Oncology
- Cell Biology
- Physiology
Background:
- Neuroendocrine (NE) differentiation is characteristic of advanced, therapy-resistant prostate cancer.
- Current treatments for NE prostate cancer are largely ineffective.
Purpose of the Study:
- To investigate alterations in regulatory volume decrease (RVD) and swelling-activated chloride current (I(Cl,swell)) during NE differentiation in prostate cancer cells.
- To identify the molecular mechanisms underlying these changes.
Main Methods:
- Utilized NE-differentiating regimens (cAMP elevation, androgen deprivation) on LNCaP prostate cancer cells.
- Measured regulatory volume decrease (RVD) and swelling-activated chloride current (I(Cl,swell)).
- Assessed expression of the ClC-3 chloride channel and calcium influx.
Main Results:
- NE differentiation augmented I(Cl,swell) and enhanced RVD in LNCaP cells.
- Increased endogenous expression of the volume-sensitive ClC-3 channel contributed to augmented I(Cl,swell).
- Weaker negative control of I(Cl,swell) by calcium influx was observed.
Conclusions:
- Enhanced RVD mechanisms in NE-differentiated prostate cancer cells may contribute to apoptosis resistance and improved survival.
- Findings suggest a link between cell volume regulation and the aggressive phenotype of NE prostate cancer.